Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0116 | 0.7701 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.2299 | 0.5846 |
Brugia malayi | glutathione reductase | 0.0046 | 0.2299 | 0.5846 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.2299 | 0.0656 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0016 | 0 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0046 | 0.2299 | 0.5846 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.2184 | 0.5554 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0116 | 0.7701 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0046 | 0.2299 | 0.5846 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.2184 | 0.2184 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.2184 | 0.5554 |
Trypanosoma cruzi | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0067 | 0.3933 | 1 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0067 | 0.3933 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.2184 | 0.2184 |
Mycobacterium tuberculosis | Probable reductase | 0.0104 | 0.6806 | 0.8837 |
Toxoplasma gondii | thioredoxin reductase | 0.0046 | 0.2299 | 0.5846 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0 | 0.5 |
Trypanosoma brucei | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0067 | 0.3933 | 1 |
Echinococcus multilocularis | FAD linked sulfhydryl oxidase ALR | 0.0067 | 0.3933 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0067 | 0.3933 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.2299 | 0.5846 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0044 | 0.2184 | 0.5554 |
Echinococcus granulosus | FAD linked sulfhydryl oxidase ALR | 0.0067 | 0.3933 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0104 | 0.6806 | 0.8837 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0016 | 0 | 0.5 |
Plasmodium vivax | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0067 | 0.3933 | 1 |
Loa Loa (eye worm) | hepatopoietin HPO2 | 0.0067 | 0.3933 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.2184 | 0.5554 |
Trypanosoma brucei | trypanothione reductase | 0.0046 | 0.2299 | 0.5846 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0116 | 0.7701 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0104 | 0.6806 | 0.8837 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0116 | 0.7701 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0104 | 0.6806 | 0.8837 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.2299 | 0.5846 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0067 | 0.3933 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0046 | 0.2299 | 0.2985 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0016 | 0 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0016 | 0 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0046 | 0.2299 | 0.5846 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0016 | 0 | 0.5 |
Brugia malayi | Augmenter of liver regeneration | 0.0067 | 0.3933 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0104 | 0.6806 | 0.8837 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.2299 | 0.0656 |
Leishmania major | trypanothione reductase | 0.0046 | 0.2299 | 0.5846 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0067 | 0.3933 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.2184 | 0.2184 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.2299 | 0.5846 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0104 | 0.6806 | 0.8837 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0067 | 0.3933 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0 | 0.5 |
Plasmodium falciparum | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0067 | 0.3933 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.2184 | 0.5554 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.2299 | 0.5846 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0016 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.